Generics

Filter

Current filters:

None

Popular Filters

1001 to 1025 of 1202 results

Lower drugs costs and insurance may help India achieve affordable medicines

01-04-2012

The next few years will spell considerable growth and change for the Indian health insurance industry,…

Asia-PacificGenericsHealthcarePharmaceuticalPricing

Horizon Pharma sues Par for infringing Duexis patent

29-03-2012

Horizon Pharma (Nasdaq: HZNP) has filed a patent infringement lawsuit in the US District Court for the…

DuexisGenericsHorizon PharmaLegalNeurologicalNorth AmericaPar PharmaceuticalPatents

Sanofi and Bayer consider Russian expansion, product launches

28-03-2012

Two European drug majors - France-based Sanofi (Euronext: SAN) and German company Bayer (BAY: DE) have…

BayerEuropeGenericsInsulinMarkets & MarketingPharmaceuticalSanofi

STADA Arz sets up subsidiary in Australia

27-03-2012

German generics drugmaker STADA Arzneimittel (SAZ: GR) has established a subsidiary based in Sydney,…

Asia-PacificGenericsMarkets & MarketingSTADA Arzneimittel

Consumer groups call for condemnation of ACTA independent of ECJ

27-03-2012

Health-related consumer groups Health Action International (HAI) Europe, Oxfam, Medecins Sans Frontieres…

EuropeGenericsGlobalLegalPatentsPharmaceuticalPoliticsRegulation

BRICS bringing new resources to health and development as other donors lag

26-03-2012

So-called BRICS countries, comprising Brazil, Russia, India, China and South Africa, are injecting new…

FinancialGenericsGlobalHealthcarePharmaceuticalResearch

US FDA ties up another Biosimilars loose end

23-03-2012

The US Food and Drug Administration issuance of three long-awaited and highly anticipated draft biosimilar…

BiotechnologyGenericsNorth AmericaRegulation

Goldshield and affiliates rebrand as Mercury Pharma

22-03-2012

Goldshield, an international speciality pharmaceutical company selling niche generic prescription and…

GenericsGoldshieldMarkets & MarketingMercury Pharma

FDA approves first generics of Roche osteo drug Boniva

20-03-2012

The US Food and Drug Administration yesterday approved the first generic versions of Boniva (ibandronate)…

Anti-Arthritics/RheumaticsApotexBonivaGenericsMylan LaboratoriesNorth AmericaOrchid HealthcareRegulationRoche

Watson confirms Abbott Niaspan patent challenge

19-03-2012

USA-based Watson Pharmaceuticals (NYSE: WPI) has confirmed that its subsidiary, Watson Laboratories,…

Abbott LaboratoriesCardio-vascularGenericsNiaspanNorth AmericaPatentsWatson Pharmaceuticals

MSF urges more compulsory drug licensing in India

19-03-2012

In the wake of India granting its first compulsory drug license - to local firm Natco Pharma for a genric…

Asia-PacificGenericsPatentsPharmaceutical

Flamel Tech acquires US firm Eclat Pharma; reports loss

19-03-2012

Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired…

Eclat PharmaceuticalsFinancialFlamel TechnologiesGenericsMergers & AcquisitionsPharmaceutical

United Therapeutics sues Sandoz over Remodulin patent infringement

16-03-2012

United Therapeutics (Nasdaq: UTHR) says that it has filed a law suit in the US District Court for the…

Cardio-vascularGenericsLegalNorth AmericaNovartisPatentsPharmaceuticalRemodulinSandozUnited Therapeutics

Likelihood of big uptake of biosimilars by 2020 questioned

15-03-2012

The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this…

BiotechnologyGenericsGlobalMarkets & MarketingPatentsRegulation

Hikma earnings down despite 25.6% revenue growth

14-03-2012

Fast-growing Jordan headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) delivered what it called…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

1001 to 1025 of 1202 results

Back to top